Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Clinical trial NCT07725380 · RECRUITING
Trial details
- NCT number
- NCT07725380
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2031-08-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.